Fermer le menu


Member of Lyonbiopole


INOVOTION offer a unique approach for early identification of low-value molecules in oncology drug discovery, based on new chick-egg assays. Easily accessible to a very wide base of potential users, our assays are faster, more complete, more reliable and less expensive. We help chemists and biologists in biotech or big pharmaceutical companies and academic labs, to develop new molecules without going over budget. Inovotion new approach adds an intermediate step, between in vitro testing and the pre-clinical assays on mice, to reduce the level of risk. Our assays are currently dedicated to evaluate the efficacy and the toxicity during lead validation and optimization phases and the target validation.,This very accessible technology reducing the associated time and cost, allows rapid GO/NO GO decisions without requiring animal testing and opens up new perspectives for the research projects.




Strategic application domain: Medical Technologies

Application market: Oncology

Type of activity: CRO - Tools - R&D platform

Technologies: Antibodies - Protein - Peptide, Screening methods or services

Created on may 4th, 2015 - 16 employees



Biopolis - 5 avenue du Grand Sablon 38700 La Tronche



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.

R&D projects